We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Lifeline Sci. S | LSE:LSI | London | Ordinary Share | COM SHS USD0.01 (REG S) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 137.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jun 2019 to Jun 2024
TIDMLSI TIDMLSIC
RNS Number : 2872I
Lifeline Scientific, Inc
28 May 2014
Lifeline Scientific
("Lifeline" or the "Company")
Posting of Annual Report & Notice of AGM
Lifeline Scientific (AIM: LSIC, LSI), the transplantation technology company, confirms that the Annual Report and Accounts for the year ended 31 December 2013 ("2013 Annual Report and Accounts"), the Notice of the Annual General Meeting ("AGM") and a Form of Proxy were posted to shareholders on 23 May 2014.
The AGM is to be held at 8:30 am US CDT on 19 June 2014 at the Westin Hotel, 400 Park Boulevard, Itasca, IL 60143, USA.
A copy of the 2013 Annual Report and Accounts is available on the Company's website: www.lifeline-scientific.com
For further information, please contact:
Lifeline Scientific, Inc. www.lifeline-scientific.com David Kravitz, CEO Tel: +1 847 294 0300 Lisa Kieres, CFO Tel: +1 847 294 0300 Panmure Gordon (UK) Limited Tel: +44 (0)20 7886 2500 Freddy Crossley/Fred Walsh (Corporate Finance) Adam Pollock (Corporate Broking) Walbrook Tel: +44 (0)20 7933 8780 or lifeline@walbrookpr.com Paul McManus Mob: +44 (0)7980 541 893 Mike Wort Mob: +44 (0)7900 608 002
About Lifeline Scientific Inc.
Lifeline Scientific, Inc. is a Chicago-based global medical technology company with regional offices in Brussels and Sao Paulo. The Company's focus is the development of innovative products that improve transplant outcomes and lower the overall costs of transplantation. Its lead product is the market-leading and clinically validated LifePort Kidney Transporter. Devices for preservation of the liver, pancreas, heart and lung are in late stage pre-clinical development. For more information please visit www.lifeline-scientific.com
About LifePort Kidney Transporter
Created with the challenges of organ recovery and transport in mind, LifePort Kidney Transporter is a proprietary medical device designed to provide improved kidney preservation, evaluation and transport prior to transplantation. Today, it is widely recognised as the world's leading machine preservation device for kidneys. Employed by surgeons in over 160 leading transplant programmes in 27 countries worldwide, LifePorts have successfully preserved over 47,000 kidneys indicated for clinical transplant. For more information please visit www.organ-recovery.com
Lifeline Scientific, Inc. Shares
As a US Company listed on the London Stock Exchange's AIM exchange, Lifeline Scientific, Inc. (AIM: LSIC, LSI) trades under two lines of stock. While affiliates of the Company are required to hold restricted (RegS) shares, all others may hold restricted or unrestricted shares. Unrestricted shares may be electronically traded through the CREST system. Both lines of stock have identical rights, preferences and privileges. Non-affiliates may transfer restricted shares to the unrestricted line after purchase through the Company's registrar. Total shares outstanding for the Company at this time are 19,446,959.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSQKFDQABKDAPB
1 Year Lifeline Sci. S Chart |
1 Month Lifeline Sci. S Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
